JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaJaroslav Žák, John R. Teijaro, Isaraphorn Pratumchai et al.|Science|2024Cited by 173
The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myelomaG. Wei Xu, Aaron D. Schimmer, Mohsin Ali et al.|Blood|2010Cited by 168
The antihelmintic flubendazole inhibits microtubule function through a mechanism distinct from Vinca alkaloids and displays preclinical activity in leukemia and myelomaPaul A. Spagnuolo, Aaron D. Schimmer, Sumaiya Sharmeen et al.|Blood|2010Cited by 149
Inhibition of the Sodium Potassium Adenosine Triphosphatase Pump Sensitizes Cancer Cells to Anoikis and Prevents Distant Tumor FormationCraig D. Simpson, Aaron D. Schimmer, Imtiaz A. Mawji et al.|Cancer Research|2009Cited by 103
Discovery of Small Molecules for the Reversal of T Cell ExhaustionBrett S. Marro, Michael B. A. Oldstone, Jaroslav Žák et al.|Cell Reports|2019Cited by 49